Mark Sheptoff Financial Planning Decreased Its Bristol Myers Squibb Co (BMY) Stake as Stock Price Declined; Mercury Sys (MRCY) Position Held by Axiom International Investors Llc

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Axiom International Investors Llc increased its stake in Mercury Sys Inc (MRCY) by 163.98% based on its latest 2018Q3 regulatory filing with the SEC. Axiom International Investors Llc bought 73,697 shares as the company’s stock declined 11.89% with the market. The institutional investor held 118,640 shares of the electrical products company at the end of 2018Q3, valued at $6.56 million, up from 44,943 at the end of the previous reported quarter. Axiom International Investors Llc who had been investing in Mercury Sys Inc for a number of months, seems to be bullish on the $2.30 billion market cap company. The stock decreased 0.11% or $0.05 during the last trading session, reaching $47.44. About 117,560 shares traded. Mercury Systems, Inc. (NASDAQ:MRCY) has declined 4.34% since January 9, 2018 and is downtrending. It has underperformed by 4.34% the S&P500. Some Historical MRCY News: 25/04/2018 – Recall in our report, we said pay very close attention to $MRCY gross margins. Yet, another miss, this time a bigger miss than last qtr (even adj for Themis lower margin contribution); 18/04/2018 – There is no rational reason why $MRCY is the highest valued multi-billion $ aerospace and defense name in the industry given the #challenges it faces; 04/05/2018 – Stephens Inv Mgmt Group Buys 1.1% Position in Mercury Systems; 18/04/2018 – Look how $MRCY insiders timed their selling. Initiated a 10b5-1 ahead of the DoD audit investigation. Looks very very suspicious @SEC_Enforcement #skeptic; 17/04/2018 – Mercury Systems May Benefit, Industry Posts 27th Straight Gain; 24/04/2018 – Mercury Systems Sees 4Q Rev $146.7M-$151.7M; 19/03/2018 – Mercury Systems Announces Latest Briefcase-Size Rugged Mini Server; 25/04/2018 – Mercury Systems Demonstrates Safety-Certifiable Multicore Graphics Rendering Optimized for Next-Generation Army Aviation Missio; 27/04/2018 – Time to exercise our right to report accounting concerns to Mercury Systems $MRCY, thankfully they just put this program in place for interested parties; 19/04/2018 – Just brought to our attention that leading forensic research firm CFRA had also written a cautionary report on $MRCY in December 2017. For those interested, we suggest tracking it down also #skeptic

Mark Sheptoff Financial Planning Llc decreased its stake in Bristol Myers Squibb Co (BMY) by 68.52% based on its latest 2018Q3 regulatory filing with the SEC. Mark Sheptoff Financial Planning Llc sold 8,076 shares as the company’s stock declined 13.60% with the market. The institutional investor held 3,710 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $230,000, down from 11,786 at the end of the previous reported quarter. Mark Sheptoff Financial Planning Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $76.71 billion market cap company. The stock decreased 2.08% or $1 during the last trading session, reaching $46.99. About 13.96 million shares traded or 19.37% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 14.97% since January 9, 2018 and is downtrending. It has underperformed by 14.97% the S&P500. Some Historical BMY News: 23/05/2018 – Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line; 13/04/2018 – Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy in a Predominantly Chinese Population with Previously Treated Non-Small Cell Lung Cancer (NSCLC); 16/04/2018 – Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing lmprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives lnnate and Adaptive Immune Responses in Tumors; 15/03/2018 – U.K. DEFENCE SECERETARY WILLIAMSON GIVES SPEECH IN BRISTOL; 03/05/2018 – BMY: EMA VALIDATED TYPE II VARIATION APPLICATION FOR OPDIVO; 16/04/2018 – #AACR18 first-line NSCLC I/O showdown in NEJM $MRK Keynote-189; 26/03/2018 – BRISTOL-MYERS SQUIBB CO – CHMP RECOMMENDATION OF OPDIVO WILL NOW BE REVIEWED BY EUROPEAN COMMISSION; 09/04/2018 – CANADA OKS TECENTRIQ FOR METASTATIC NON-SMALL CELL LUNG CANCER; 15/05/2018 – STANDARD LITHIUM – WILL INITIALLY BUY RIGHT TO CONDUCT LITHIUM BRINE EXPLORATION ACTIVITIES ON PROPERTIES LOCATED IN BRISTOL DRY LAKE, CADIZ DRY LAKE; 04/04/2018 – Rhode Island DoA: Bristol Fourth of July Committee Wed, 4/4/2018, 8:00 PM

Axiom International Investors Llc, which manages about $10.22 billion and $3.50 billion US Long portfolio, decreased its stake in Upland Software Inc by 31,465 shares to 60,425 shares, valued at $1.95M in 2018Q3, according to the filing. It also reduced its holding in Coresite Rlty Corp (NYSE:COR) by 9,000 shares in the quarter, leaving it with 17,285 shares, and cut its stake in Loxo Oncology Inc (NASDAQ:LOXO).

Since August 1, 2018, it had 0 buys, and 10 sales for $5.24 million activity. THIBAUD DIDIER M C sold $192,710 worth of stock.

Among 10 analysts covering Mercury (NASDAQ:MRCY), 6 have Buy rating, 1 Sell and 3 Hold. Therefore 60% are positive. Mercury had 29 analyst reports since August 25, 2015 according to SRatingsIntel. Noble Financial maintained the shares of MRCY in report on Wednesday, January 24 with “Hold” rating. The rating was maintained by SunTrust on Monday, January 8 with “Buy”. The rating was maintained by Robert W. Baird on Wednesday, January 24 with “Buy”. The firm earned “Outperform” rating on Wednesday, October 25 by Robert W. Baird. The stock has “Sell” rating by Bank of America on Wednesday, April 25. The stock has “Hold” rating by Jefferies on Tuesday, September 5. The firm earned “Hold” rating on Friday, May 26 by Jefferies. Bank of America upgraded the stock to “Buy” rating in Tuesday, January 24 report. The rating was maintained by SunTrust on Wednesday, October 18 with “Buy”. The stock has “Buy” rating by Robert W. Baird on Wednesday, April 25.

More notable recent Mercury Systems, Inc. (NASDAQ:MRCY) news were published by: Globenewswire.com which released: “Mercury Systems Announces 100 Gbps OpenVPX Backplane Data Transmission Rates – GlobeNewswire” on December 20, 2018, also Seekingalpha.com with their article: “Multiple Material Adverse Effects Converging On Mercury Systems Suggest 50% To 85% Downside Risk – Seeking Alpha” published on April 19, 2018, Globenewswire.com published: “Hagens Berman Reminds Investors in Mercury Systems (NASDAQ: MRCY) of the September 10, 2018 Securities Class Action Lead Plaintiff Deadline – GlobeNewswire” on August 01, 2018. More interesting news about Mercury Systems, Inc. (NASDAQ:MRCY) were released by: Globenewswire.com and their article: “Mercury Systems Receives $3.8M Millimeter Wave Microelectronics Order for Homeland Security Application – GlobeNewswire” published on May 08, 2018 as well as Seekingalpha.com‘s news article titled: “Mercury Systems +18.8% after Q4 beats, upside revenue guide – Seeking Alpha” with publication date: August 01, 2018.

Investors sentiment decreased to 1.11 in Q3 2018. Its down 0.27, from 1.38 in 2018Q2. It turned negative, as 15 investors sold MRCY shares while 64 reduced holdings. 34 funds opened positions while 54 raised stakes. 47.81 million shares or 3.91% less from 49.75 million shares in 2018Q2 were reported. Signaturefd Ltd Liability reported 0% stake. Strs Ohio owns 1,500 shares or 0% of their US portfolio. Timpani Mngmt Llc has invested 0.57% in Mercury Systems, Inc. (NASDAQ:MRCY). Wellington Mgmt Gp Limited Liability Partnership reported 0.01% in Mercury Systems, Inc. (NASDAQ:MRCY). Cortina Asset Mgmt Lc holds 1.33% or 515,967 shares in its portfolio. Emerald Advisers Incorporated Pa has invested 0.76% in Mercury Systems, Inc. (NASDAQ:MRCY). Suntrust Banks reported 0% stake. Ironwood Inv Ltd Limited Liability Company holds 1.95% or 50,391 shares in its portfolio. Eagle Asset Mngmt holds 0.03% of its portfolio in Mercury Systems, Inc. (NASDAQ:MRCY) for 122,475 shares. Louisiana State Employees Retirement System invested 0.05% in Mercury Systems, Inc. (NASDAQ:MRCY). Us Retail Bank De holds 22,671 shares or 0% of its portfolio. Citadel Limited Com has invested 0% of its portfolio in Mercury Systems, Inc. (NASDAQ:MRCY). State Street Corp owns 2.37M shares. American Group Inc Inc stated it has 37,078 shares or 0.01% of all its holdings. Brown Advisory Incorporated stated it has 406,304 shares or 0.06% of all its holdings.

Investors sentiment increased to 0.88 in 2018 Q3. Its up 0.10, from 0.78 in 2018Q2. It is positive, as 41 investors sold BMY shares while 532 reduced holdings. 119 funds opened positions while 388 raised stakes. 1.14 billion shares or 0.62% less from 1.14 billion shares in 2018Q2 were reported. Walter And Keenan Fincl Consulting Communication Mi Adv holds 0.16% or 8,450 shares in its portfolio. Schroder Investment Management has invested 0.36% in Bristol-Myers Squibb Company (NYSE:BMY). Cibc Fincl Bank Usa holds 7,615 shares or 0.06% of its portfolio. Ibm Retirement Fund stated it has 29,499 shares. Arrowstreet Cap Lp reported 2.03% in Bristol-Myers Squibb Company (NYSE:BMY). Boyd Watterson Asset Llc Oh holds 0.14% in Bristol-Myers Squibb Company (NYSE:BMY) or 3,811 shares. 6,486 were reported by Roof Eidam And Maycock Adv. Princeton Strategies Grp Incorporated Lc reported 35,827 shares or 0.58% of all its holdings. First Hawaiian State Bank holds 0.1% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 29,935 shares. Private Harbour Investment Management And Counsel Ltd Liability Corporation holds 1.08% or 19,366 shares in its portfolio. Field & Main Bancorp reported 15,015 shares stake. Westwood Gru Inc owns 14,460 shares. Parsec Financial invested 0.04% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Fund Sa reported 1.55M shares. Cutter & Brokerage Inc holds 35,707 shares.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 24 before the open. They expect $0.84 earnings per share, up 23.53% or $0.16 from last year’s $0.68 per share. BMY’s profit will be $1.37 billion for 13.99 P/E if the $0.84 EPS becomes a reality. After $1.09 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -22.94% negative EPS growth.

Mark Sheptoff Financial Planning Llc, which manages about $218.89 million and $145.79M US Long portfolio, upped its stake in Boise Cascade Co Del (NYSE:BCC) by 16,050 shares to 16,650 shares, valued at $613,000 in 2018Q3, according to the filing.

More notable recent Bristol-Myers Squibb Company (NYSE:BMY) news were published by: Streetinsider.com which released: “Bristol-Myers Squibb (BMY) call put ratio 1 call to 1 put with focus on June 44 puts and June 55 calls – StreetInsider.com” on January 03, 2019, also Fool.com with their article: “Is Bristol-Myers Squibb Company a Buy? – The Motley Fool” published on September 09, 2018, Seekingalpha.com published: “You Should Not Miss Bristol-Myers Squibb In 2018 – Seeking Alpha” on August 11, 2018. More interesting news about Bristol-Myers Squibb Company (NYSE:BMY) were released by: Seekingalpha.com and their article: “Idera Pharma down 11% premarket on updated mid-stage tilsotolimod data – Seeking Alpha” published on December 14, 2018 as well as Streetinsider.com‘s news article titled: “Bristol-Myers Squibb (BMY) Reports Positive CHMP Opinion Recommending Sprycel for Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive ALL – StreetInsider.com” with publication date: December 17, 2018.

Among 25 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 1 Sell and 16 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 100 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was upgraded by SunTrust to “Buy” on Monday, October 30. Piper Jaffray maintained the stock with “Hold” rating in Thursday, July 27 report. The stock has “Overweight” rating by JP Morgan on Monday, October 8. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Buy” rating given on Friday, February 16 by Citigroup. The stock has “Outperform” rating by BMO Capital Markets on Thursday, December 6. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Market Perform” rating given on Monday, July 23 by BMO Capital Markets. Berenberg downgraded it to “Hold” rating and $70 target in Thursday, August 11 report. Barclays Capital maintained the stock with “Equal-Weight” rating in Friday, October 13 report. The company was maintained on Monday, February 26 by Jefferies. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) on Monday, July 17 with “Buy” rating.

Mercury Systems, Inc. (NASDAQ:MRCY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.